Right to Try Psilocybin

Right to Try Psilocybin (RTTP) is community group that was created by a wide-array of concerned patients and advocates in the Spring of 2022. After months of stonewalling and inaction by the Drug Enforcement Administration concerning patient access to psilocybin, RTTP organized a massive direct action at the DEA HQ in Arlington, Virginia, which resulted in the arrests of 17 advocates. RTTP believes that the Right to Try Act of 2018 covers all investigational drugs, including those listed in on Schedule I of the Controlled Substances Act and supports any new legislation that ensures those with life-threatening conditions access to psilocybin (and any other investigational psychedelic drug which meets the requirements of RTT law).


Leave a Reply

Your email address will not be published. Required fields are marked *